1. Home
  2. CBUS vs ACOG Comparison

CBUS vs ACOG Comparison

Compare CBUS & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBUS
  • ACOG
  • Stock Information
  • Founded
  • CBUS 2010
  • ACOG 2000
  • Country
  • CBUS United States
  • ACOG Canada
  • Employees
  • CBUS N/A
  • ACOG N/A
  • Industry
  • CBUS Agricultural Chemicals
  • ACOG
  • Sector
  • CBUS Industrials
  • ACOG
  • Exchange
  • CBUS Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • CBUS 75.5M
  • ACOG 80.3M
  • IPO Year
  • CBUS 2017
  • ACOG N/A
  • Fundamental
  • Price
  • CBUS $1.41
  • ACOG $8.00
  • Analyst Decision
  • CBUS Strong Buy
  • ACOG Strong Buy
  • Analyst Count
  • CBUS 3
  • ACOG 1
  • Target Price
  • CBUS $22.00
  • ACOG $20.00
  • AVG Volume (30 Days)
  • CBUS 190.8K
  • ACOG 66.4K
  • Earning Date
  • CBUS 08-14-2025
  • ACOG 08-14-2025
  • Dividend Yield
  • CBUS N/A
  • ACOG N/A
  • EPS Growth
  • CBUS N/A
  • ACOG N/A
  • EPS
  • CBUS N/A
  • ACOG N/A
  • Revenue
  • CBUS $4,846,000.00
  • ACOG $4,586,341.00
  • Revenue This Year
  • CBUS $31.23
  • ACOG N/A
  • Revenue Next Year
  • CBUS $70.93
  • ACOG $149.89
  • P/E Ratio
  • CBUS N/A
  • ACOG N/A
  • Revenue Growth
  • CBUS 63.66
  • ACOG N/A
  • 52 Week Low
  • CBUS $1.35
  • ACOG $3.75
  • 52 Week High
  • CBUS $8.65
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • CBUS 40.44
  • ACOG N/A
  • Support Level
  • CBUS $1.46
  • ACOG N/A
  • Resistance Level
  • CBUS $1.58
  • ACOG N/A
  • Average True Range (ATR)
  • CBUS 0.10
  • ACOG 0.00
  • MACD
  • CBUS -0.00
  • ACOG 0.00
  • Stochastic Oscillator
  • CBUS 20.69
  • ACOG 0.00

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: